• Innovation built on trust
    Innovation built on trust
    The BF Biosciences manufacturing facility is a poineer in the biotechnology sector in Pakistan
  • Innovation built on trust
    Innovation built on trust
    The BF Biosciences manufacturing facility is a poineer in the biotechnology sector in Pakistan
  • Innovation built on trust
    Innovation built on trust
    The BF Biosciences manufacturing facility is a poineer in the biotechnology sector in Pakistan
  • Innovation built on trust
    Innovation built on trust
    The BF Biosciences manufacturing facility is a poineer in the biotechnology sector in Pakistan
  • Innovation built on trust
    Innovation built on trust
    The BF Biosciences manufacturing facility is a poineer in the biotechnology sector in Pakistan

Biotech Pharmaceutical Plant in Pakistan

Providing best-in-industry returns
BF Biosciences Ltd Limited is a publicly listed company with shares quoted on the Karachi Stock Exchange (KSE), Lahore and Islamabad Stock Exchanges.

Read more

BF Biosciences in the World

View our International Presence
We are taking our heritage of trust and credibility to a growing number of international markets, providing life saving drugs in cardiology, hepatology, cancer and other important disease areas.

Read more

Our Partner

View Our CSR Initiatives
At BF Biosciences Limited, we take great pride in our Social Responsibility initiatives in the fields of education, health and culture.

Read more

Facts About BF

BF Biosciences Limited

BF Biosciences Limited is a joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina and Pakistan's first biopharmaceutical production facility, designed to USFDA standards.

In 2002, Ferozsons and Bagó entered into commercial partnership to launch the Bagó range of quality branded generics in the field of oncology and hepatology in Pakistan. Within the first two years, together we achieved a leadership position, becoming one of the top 3 companies in both Oncology and hepatology segments.

Our Porducts

Oxaltie Injection

Therapeutic Segment: ONCOLOGY

Area: Colorectal Cancer

Oxaltie injections contain Oxaliplatin 50 mg or 100 mg in glass vials. Oxaliplatin is a platinum-based compound used in chemotherapy regimens for the treatment of colorectal cancer.

Peg-INF

Therapeutic Segment: HEPATOLOGY

Area: Hepatitis-C

Peg-INF (Pegylated Interferon Alpha 2a 180 mcg – 40KD) is available in vials containing 1 ml ready-to-inject solution. Peginterferon is part of a once-weekly regimen indicated in the treatment of chronic Hepatitis C in combination with Ribavirin.

Donataxel Injection

Therapeutic Segment: ONCOLOGY

Area: Breast Cancer

Donataxel contains Docetaxel 20 mg or 80 mg in glass vials. Docetaxel is approved for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed. It is also used in regimens to treat ovarian cancer.